Correlation Between SAB Biotherapeutics and Sotera Health
Can any of the company-specific risk be diversified away by investing in both SAB Biotherapeutics and Sotera Health at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SAB Biotherapeutics and Sotera Health into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SAB Biotherapeutics and Sotera Health Co, you can compare the effects of market volatilities on SAB Biotherapeutics and Sotera Health and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SAB Biotherapeutics with a short position of Sotera Health. Check out your portfolio center. Please also check ongoing floating volatility patterns of SAB Biotherapeutics and Sotera Health.
Diversification Opportunities for SAB Biotherapeutics and Sotera Health
-0.47 | Correlation Coefficient |
Very good diversification
The 3 months correlation between SAB and Sotera is -0.47. Overlapping area represents the amount of risk that can be diversified away by holding SAB Biotherapeutics and Sotera Health Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sotera Health and SAB Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SAB Biotherapeutics are associated (or correlated) with Sotera Health. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sotera Health has no effect on the direction of SAB Biotherapeutics i.e., SAB Biotherapeutics and Sotera Health go up and down completely randomly.
Pair Corralation between SAB Biotherapeutics and Sotera Health
Assuming the 90 days horizon SAB Biotherapeutics is expected to generate 9.41 times more return on investment than Sotera Health. However, SAB Biotherapeutics is 9.41 times more volatile than Sotera Health Co. It trades about 0.17 of its potential returns per unit of risk. Sotera Health Co is currently generating about -0.3 per unit of risk. If you would invest 5.00 in SAB Biotherapeutics on August 28, 2024 and sell it today you would earn a total of 1.88 from holding SAB Biotherapeutics or generate 37.6% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 85.71% |
Values | Daily Returns |
SAB Biotherapeutics vs. Sotera Health Co
Performance |
Timeline |
SAB Biotherapeutics |
Sotera Health |
SAB Biotherapeutics and Sotera Health Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with SAB Biotherapeutics and Sotera Health
The main advantage of trading using opposite SAB Biotherapeutics and Sotera Health positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SAB Biotherapeutics position performs unexpectedly, Sotera Health can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sotera Health will offset losses from the drop in Sotera Health's long position.SAB Biotherapeutics vs. SAB Biotherapeutics | SAB Biotherapeutics vs. Jasper Therapeutics | SAB Biotherapeutics vs. NRx Pharmaceuticals |
Sotera Health vs. Qiagen NV | Sotera Health vs. Aclaris Therapeutics | Sotera Health vs. Neogen | Sotera Health vs. RadNet Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |